| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2024 | BTAI Bioxcel Therapeutics, Inc. | Mehta Vimal92 | CEO And President | Sell | 2,134 | $1.28 | $2,738.99 | -4.3% | -51.9% | -92.3% | |
| Jun 17, 2024 | BTAI Bioxcel Therapeutics, Inc. | Yocca Frank88 | Chief Scientific Officer | Sell | 372 | $1.28 | $476.16 | -2.7% | -51.9% | -92.3% | |
| Jun 14, 2024 | INIS International Isotopes Inc | Cox W Matthew | Chief Financial Officer | Buy | 239,669 | $0.04 | $9,586.76 | +42.2% | - | - | |
| Jun 14, 2024 | VRNO Verano Holdings Corp. | Archos George Peter | Chief Executive Officer | Sell | 38,085 | $3.61 | $137,357.36 | -0.3% | - | - | |
| Jun 14, 2024 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 3,600 | $287.22 | $1,033,984.24 | -52.4% | +18.4% | -1.6% | |
| Jun 14, 2024 | LLY Eli Lilly & Co | Lilly Endowment Inc | - | Sell | 15,022 | $882.47 | $13,256,489.99 | - | +6.4% | -6.7% | |
| Jun 14, 2024 | VRNO Verano Holdings Corp. | Miles Aaron Nathaniel | Chief Investment Officer | Sell | 30,275 | $3.61 | $109,189.81 | -16.3% | - | - | |
| Jun 14, 2024 | VRNO Verano Holdings Corp. | Tarapchak Richard C | EVP, Finance | Sell | 14,599 | $3.61 | $52,652.75 | -16.5% | - | - | |
| Jun 14, 2024 | VREOF Vireo Growth Inc. | Chicago Atlantic Credit Opportunities, LLC | 10% Owner | Buy | 1,300,078 | $0.54 | $699,962.00 | +114,242% | - | - | |
| Jun 14, 2024 | VRNO Verano Holdings Corp. | Thompson Destiny Lynn | Chief People Officer | Sell | 29,029 | $3.61 | $104,695.99 | -24.2% | - | - | |
| Jun 14, 2024 | TLPH Talphera, Inc. | Aslam Shakil | Chief Medical Officer | Buy | 5,695 | $1.06 | $6,038.10 | +8.8% | -15.1% | -53.8% | |
| Jun 14, 2024 | VTRS Viatris Inc | Malik Rajiv61 | Director | Sell | 349,960 | $10.26 | $3,591,023.87 | -18.4% | +15.5% | -12.3% | |
| Jun 14, 2024 | TLPH Talphera, Inc. | Angotti Vincent J.56 | Chief Executive Officer | Buy | 10,000 | $0.99 | $9,856.15 | +1.9% | -15.1% | -53.8% | |
| Jun 14, 2024 | BCRX Biocryst Pharmaceuticals Inc | Heggie Theresa | Director | Sell | 6,698 | $6.11 | $40,924.78 | -11.2% | +25.6% | +68.1% | |
| Jun 14, 2024 | INIS International Isotopes Inc | Bagerdjian Shahe | Pres. &CEO | Buy | 250,000 | $0.04 | $10,000.00 | +2.9% | - | - | |
| Jun 13, 2024 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 3,600 | $285.48 | $1,027,715.79 | -16.3% | +20.4% | -1.5% | |
| Jun 13, 2024 | ANIP Ani Pharmaceuticals Inc | Cook Meredith50 | Sr. VP, General Counsel &Sec. | Sell | 250 | $63.80 | $15,950.00 | -0.4% | -14.1% | -1.1% | |
| Jun 13, 2024 | LNTH Lantheus Holdings, Inc. | Sabens Andrea47 | Chief Accounting Officer | Sell | 341 | $79.77 | $27,201.57 | -0.5% | +27.3% | -2.8% | |
| Jun 13, 2024 | UTHR United Therapeutics Corp | Causey Christopher59 | Director | Sell | 2,000 | $281.53 | $563,054.80 | -32.3% | +20.4% | -1.5% | |
| Jun 13, 2024 | PCRX Pacira Biosciences, Inc. | Gaugler Daryl67 | Chief Operating Officer | Sell | 1,000 | $28.38 | $28,380.00 | -0.9% | -54.2% | -14.6% | |
| Jun 13, 2024 | PCRX Pacira Biosciences, Inc. | Hastings Paul J77 | Director | Sell | 880 | $28.38 | $24,974.40 | -6.5% | -54.2% | -14.6% | |
| Jun 13, 2024 | PCRX Pacira Biosciences, Inc. | Williams Kristen76 | Chief Administrative Officer | Sell | 7,452 | $28.38 | $211,487.76 | -6.8% | -54.2% | -14.6% | |
| Jun 12, 2024 | PCRX Pacira Biosciences, Inc. | Riker Lauren76 | Senior Vice President, Finance | Sell | 3,970 | $28.72 | $114,018.40 | -9.4% | -53.8% | -14.7% | |
| Jun 12, 2024 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 7,200 | $278.45 | $2,004,850.66 | -32.9% | +21.5% | +1.5% | |
| Jun 11, 2024 | HIMS Hims & Hers Health, Inc. | Boughton Soleil | Chief Legal Officer | Sell | 2,510 | $21.47 | $53,889.70 | -1.6% | -36.6% | +161.2% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.